Related Experiment Video
Updated: Aug 17, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6
Shinichiro Takahashi1, Hideo Harigae, Keiko Kumura Ishii
1Department of Clinical Laboratory Medicine, Tohoku University School of Medicine, 1-1 Seiryou-machi, Aobaku, Sendai 980-8574, Japan. shintak@mail.tains.tohoku.ac.jp
Abstract:
Activating mutations or over-expression of the Flt3 is prevalent in acute myeloblastic leukemia (AML), associated with activation of Ras/MAP kinase and other signaling pathways. In this study, we addressed the role of Flt3 in the activation of nuclear factor-kappa B (NF-kappaB), which is a target molecule of these kinase pathways. In BaF3 cells stably expressing Flt3, a NF-kappaB-responsive reporter was upregulated and its target gene, IL-6, was increased by the involvement of Flt3-ERK/MAPK-NF-kappaB pathway. Furthermore, we found a modest positive correlation (r=0.35, p=0.096) between Flt3 and IL-6 mRNA expression in 24 AML specimens. These results suggest a role of Flt3 over-expression in NF-kappaB pathway.
Insights
Activating Fms-like tyrosine kinase 3 (Flt3) mutations in acute myeloblastic leukemia (AML) activate signaling pathways. This study reveals Flt3 signaling upregulates nuclear factor-kappa B (NF-kappaB) and its target IL-6, suggesting Flt3
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Activating mutations or over-expression of Fms-like tyrosine kinase 3 (Flt3) are common in acute myeloblastic leukemia (AML).
- Flt3 signaling activates Ras/MAP kinase and other pathways crucial in cancer development.
- Nuclear factor-kappa B (NF-kappaB) is a key transcription factor regulated by these kinase pathways.
Purpose of the Study:
- To investigate the role of Flt3 in the activation of the NF-kappaB signaling pathway.
- To determine if Flt3 signaling influences the expression of NF-kappaB target genes, such as Interleukin-6 (IL-6).
Main Methods:
- Utilized BaF3 cells engineered for stable Flt3 expression.
- Employed an NF-kappaB-responsive reporter assay to measure pathway activation.
- Quantified IL-6 mRNA expression in cell lines and primary AML specimens.
- Analyzed the correlation between Flt3 and IL-6 mRNA levels in AML patient samples.
Main Results:
- Flt3 expression led to the upregulation of an NF-kappaB-responsive reporter in BaF3 cells.
- Flt3 signaling, specifically through the Flt3-ERK/MAPK pathway, resulted in increased IL-6 expression.
- A modest positive correlation (r=0.35, p=0.096) was observed between Flt3 and IL-6 mRNA levels in 24 AML specimens.
Conclusions:
- Flt3 signaling plays a role in the activation of the NF-kappaB pathway.
- Flt3 over-expression may contribute to the pathogenesis of AML by upregulating NF-kappaB and IL-6.
- These findings highlight a potential therapeutic target in Flt3-driven AML.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway

